Top Markets
#1 Cortex Cortex +173.72%
#2 Helium Helium +60.27%
#3 GEKKO GEKKO +50.71%
#4 Pons Pons +20.78%
#5 ADO Protocol ADO Protocol +17.96%
#6 o1.exchange o1.exchange +13.64%
#7 Collect on Fanable Collect on Fanable +12.30%
#8 Status Status +11.10%
#9 龙虾 (Lobster) 龙虾 (Lobster) +10.81%
#10 Siren Siren +10.57%
Coin of the day
Cortex Cortex
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Inventiva S.A. Inventiva S.A.

Inventiva S.A.

IVA
Rangering i aksjer #8990
Inventiva S.A. is a biopharmaceutical firm currently in the clinical... Inventiva S.A. is a biopharmaceutical firm currently in the clinical development phase, specializing in creating orally administered small molecule treatments for conditions such as non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and various other ailments. Their primary drug candidate, Lanifibranor, has successfully concluded Phase IIb clinical trials for the management of NASH. Furthermore, the company is advancing Odiparcil, a compound that has finished Phase IIa clinical testing specifically for treating the MPS VI subtype. Beyond these, Inventiva maintains a development pipeline featuring several early-stage projects targeting oncology and other medical conditions. Strategic partnerships are in place with AbbVie to address autoimmune diseases, and with Boehringer Ingelheim International GmbH for innovating therapies for idiopathic pulmonary fibrosis. Established in 2011, Inventiva S.A. operates from its headquarters in Daix, France.
Aksjekurs
$4.74
Sist synkronisert: 2026-08-28
Markedsverdi
$1.12B
Endring (1 dag)
-5.77%
Endring (1 år)
-16.96%
Land
FR
Handel Inventiva S.A. (IVA)

Kategori

Healthcare
Antall utestående aksjer for Inventiva S.A. (IVA)
Antall utestående aksjer per August 2026: 0
Ifølge Inventiva S.A. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Inventiva S.A. (IVA) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH